Bill Snyder

Boston University biomedical engineer and MacArthur Fellow James Collins, Ph.D., will lecture at 3:10 p.m. Oct. 23 in the Jacobs Believed in Me Auditorium, part of the Vanderbilt School of Engineering’s Featheringill Hall. Read More

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. Read More

Kathleen Neuzil, M.D., MPH, known internationally for her efforts to expand vaccine access and delivery around the world, credited her Vanderbilt University mentors last week for guiding her to a career path that allowed her to “make a difference.” Read More

The occasional failings of science tend to draw big headlines — findings that can’t be replicated or increasing numbers of papers that are retracted because studies were improperly or even fraudulently conducted. Read More

While the national economy appears to be getting stronger, health care has entered a national recession, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the Vanderbilt University School of Medicine, told a packed audience of approximately 1,100 Vanderbilt faculty, staff and students in Langford Auditorium on Wednesday afternoon while making his annual State of the Medical Center address. Read More

Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced. Read More

Award-winning New York Times science writer and columnist Carl Zimmer will deliver the next Flexner Discovery Lecture on Thursday, Oct. 3, on setting science “right” when it goes “wrong.” Read More

Judith Warner, award-winning author of the New York Times bestseller “Perfect Madness: Motherhood in the Age of Anxiety,” will speak at Nashville’s Adventure Science Center at 7 p.m., Tuesday, Oct. 8. Read More

Vanderbilt University Medical Center has received a five-year, $1.2 million grant from the National Institutes of Health (NIH) to develop “bold and innovative approaches to broaden graduate and postdoctoral training.” Read More

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read More

Michael Merzenich, Ph.D., author of “Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life,” will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Sept. 26, in 208 Light Hall. Read More

Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD). Read More

Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism. Read More

Nobel laureate Bruce Beutler, M.D., will discuss his research on innate immunity during a noon seminar Monday, Sept. 23, in 208 Light Hall. Read More

Nora Volkow, M.D., director of the National Institute on Drug Abuse, delivers last week’s Discovery Lecture. Since she was a medical student in her native Mexico, Nora Volkow, M.D., has been fascinated by drug addiction. “It really did not make any sense … that someone would be… Read More

Alexander Sevy dons his white coat with the help of Kathleen Gould, Ph.D., at the fourth annual “Simple Beginnings” ceremony for new doctoral students. (Photo by Anne Rayner) Vanderbilt University welcomed 98 new doctoral students into its scientific community last week during the fourth annual “Simple Beginnings”… Read More

When it comes to government funding of basic science training programs for graduate students and postdoctoral fellows, Vanderbilt University Medical Center hit a grand slam this year, officials said. Read More

Nora Volkow, M.D., director of the National Institute on Drug Abuse, will begin the 2013-2014 Flexner Discovery Lecture Series next Thursday, Aug. 29, with a discussion of “Advances in Addiction Science.” Read More

Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts. Read More

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Read More